- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00771537
HIV Testing & Womens Attitudes on HIV Vaccine Trials
28 czerwca 2013 zaktualizowane przez: Gregory Zimet, Indiana University
The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial.
Adult African-American, non-Latina White, and Latina women will be recruited.
Women will initially be randomized to 4 groups: 1. no message control; 2. 1-sided message that mentions benefits of HIV testing; 3. 2-sided message that acknowledges minor opposition to testing, then refutes the opposition; and 4. 2-sided message that acknowledge stronger opposition to testing, then refutes the opposition.
Women will be offered HIV testing, then re-randomized to a similar set of 4 messages related to HIV vaccine trials.
There will therefore be 16 groups in total (4 X 4).
Przegląd badań
Szczegółowy opis
This 5-year proposal responds to PAS-03-168, "Enrolling Women and Minorities in HIV/AIDS Research Trials."
This study seeks to evaluate persuasive message interventions to increase HIV testing rates and improve acceptability of participation in a phase 3 HIV vaccine clinical trial among African-American, Latina, and White women.
We plan to evaluate 1-sided messages, which mention only the benefits of an action, versus 2-sided messages, which mention negative aspects of the action, followed by positive counterarguments.
The Health Belief Model, Inoculation and Attribution Theories will guide the research.
Participants will be women attending urban community health clinics in Indianapolis, IN. Specific Aim 1 is to identify obstacles to HIV testing and to participation in a HIV vaccine clinical trial.
This aim will be accomplished in years 1 and 2 through individual semi-structured interviews.
We will analyze data via thematic content analysis and will use interview findings to assist in the development of measures and interventions employed in the intervention phase (years 3-5).
Specific Aim 2 is to evaluate the effects of 2-sided versus 1-sided persuasive messages on rates of acceptance of rapid HIV testing.
Demographic, behavioral, and attitudinal measures will be administered via audio computer-assisted self-interview (A-CASI).
Participants will be randomized to the intervention groups via A-CASI as well.
The outcome will be acceptance/rejection of free rapid HIV testing.
This Aim will be evaluated via binary logistic regression.
Specific Aim 3 is to evaluate the effects of 2-sided versus 1-sided messages on willingness to participate in phase 3 clinical trials for a preventive HIV vaccine.
Participants will complete this 2nd A-CASI survey and will again be randomized to intervention groups.
The outcome will be a scale measuring acceptability of clinical trial participation.
This Aim will be evaluated via one-way Analysis of Variance.
This study is relevant to public health in that the results may help us to understand how to improve enrollment of women and minorities into preventive HIV vaccine clinical trials and how to encourage women and minorities to get tested for HIV.
Typ studiów
Interwencyjne
Zapisy (Rzeczywisty)
2031
Faza
- Faza 3
Kontakty i lokalizacje
Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.
Lokalizacje studiów
-
-
Indiana
-
Indianapolis, Indiana, Stany Zjednoczone, 46202
- Indiana University Medical Group Clinics
-
-
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
18 lat i starsze (Dorosły, Starszy dorosły)
Akceptuje zdrowych ochotników
Tak
Płeć kwalifikująca się do nauki
Kobieta
Opis
Inclusion Criteria:
- Female
- 18 years of age or older
- Able to understand English or Spanish
- Able to give informed consent
Exclusion Criteria:
- Not female
- Under 18 years of age
- Not able to understand English and Spanish
- Unable to give informed consent
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Badania usług zdrowotnych
- Przydział: Randomizowane
- Model interwencyjny: Przypisanie czynnikowe
- Maskowanie: Potroić
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Brak interwencji: Arm 1. Control PLUS Control
|
|
Eksperymentalny: Arm 2. Control PLUS 1-Sided
No message intervention control condition regarding HIV testing AND 1-Sided message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 3. Control PLUS 2-Sided Trivial
No message intervention control condition regarding HIV testing AND 2-Sided trivial message experimental intervention condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 4. Control PLUS 2-Sided Major
No message intervention control condition regarding HIV testing AND 2-Sided Major message experimental intervention condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 5. 1-Sided PLUS Control
1-Sided message intervention experimental condition regarding HIV testing AND No message intervention control condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 6. 1-Sided PLUS 1-Sided
1-Sided message intervention experimental condition regarding HIV testing AND 1-Sided message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 7. 1-Sided PLUS 2-Sided Trivial
1-Sided message intervention experimental condition regarding HIV testing AND 2-Sided Trivial message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Aim 8. 1-Sided PLUS 2-Sided Major
1-Sided message intervention experimental condition regarding HIV testing AND 2-Sided Major message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 9. 2-Sided Trivial PLUS Control
2-Sided Trivial message intervention experimental condition regarding HIV testing AND No message intervention control condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 10. 2-Sided Trivial PLUS 1-Sided
2-Sided Trivial message intervention experimental condition regarding HIV testing AND 1-Sided message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 11. 2-Sided Trivial PLUS 2-Sided Trivial
2-Sided Trivial message intervention experimental condition regarding HIV testing AND 2-Sided trivial message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 12. 2-Sided Trivial PLUS 2-Sided Major
2-Sided Trivial message intervention experimental condition regarding HIV testing AND 2-Sided major message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 13. 2-Sided Major PLUS Control
2-Sided major message intervention experimental condition regarding HIV testing AND No message intervention control condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 14. 2-Sided Major PLUS 1-Sided
2-Sided major message intervention experimental condition regarding HIV testing AND 1-Sided message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 15. 2-Sided Major PLUS 2-Sided Trivial
2-Sided major message intervention experimental condition regarding HIV testing AND 2-Sided trivial message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Eksperymentalny: Arm 16. 2-Sided Major PLUS 2-Sided Major
2-Sided major message intervention experimental condition regarding HIV testing AND 2-Sided major message intervention experimental condition regarding HIV vaccine clinical trial participation.
|
There are 16 pairs of messages varying in sidedness.
Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation.
Arm 2 is control + a 1-sided message.
Arm 3 is control + a trivial 2-sided message.
Arm 4 is control + a major 2-sided message.
Arm 5 is a 1-sided message + a control.
Arm 6 is a 1-sided message + a 1-sided message.
Arm 7 is a 1-sided message + a trivial 2-sided message.
Arm 8 is a 1-sided message + a major2-sided message.
Arm 9 is a trivial 2-sided message + a control.
Arm 10 is a trivial 2-sided message + a 1-sided message.
Arm 11 is a trivial 2-sided message + a trivial 2-sided message.
Arm 12 is a trivial 2-sided message + a major 2-sided message.
Arm 13 is a major 2-sided message + a control.
Arm 14 is a major 2-sided message + a 1-sided message.
Arm 15 is a major 2-sided message + a trivial 2-sided message.
Arm 16 is a major 2-sided message + a major2-sided message.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Number of Participants Who Accepted Rapid HIV Testing.
Ramy czasowe: During study visit. At approximately 30 minutes into the study visit. After part 1 of the questionnaire was completed.
|
Acceptance of rapid HIV testing.
Acceptance was assessed by actual administration of rapid oral HIV test by research staff.
|
During study visit. At approximately 30 minutes into the study visit. After part 1 of the questionnaire was completed.
|
Willingness to Participate in a HIV Vaccine Clinical Trial
Ramy czasowe: Approximately 60 minutes into the study visit, at the end of Part 2 of the questionnaire.
|
Willingness to Participate in a HIV Vaccine Clinical Trial.
Assessed via participant self-report with 6 items on Part 2 of the questionnaire.
Item responses measured on 5-point Likert-type scale ranging from Strongly Disagree (value = 1) to Strongly Agree (value = 5).
|
Approximately 60 minutes into the study visit, at the end of Part 2 of the questionnaire.
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Sponsor
Publikacje i pomocne linki
Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.
Publikacje ogólne
- Burrage JW, Zimet GD, Cox DS, Cox AD, Mays RM, Fife RS, Fife KH. The Centers for Disease Control and Prevention revised recommendations for HIV testing: reactions of women attending community health clinics. J Assoc Nurses AIDS Care. 2008 Jan-Feb;19(1):66-74. doi: 10.1016/j.jana.2007.11.003.
- Kasting ML, Cox AD, Cox D, Fife KH, Katz BP, Zimet GD. The effects of HIV testing advocacy messages on test acceptance: a randomized clinical trial. BMC Med. 2014 Nov 6;12:204. doi: 10.1186/s12916-014-0204-4.
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów
1 listopada 2006
Zakończenie podstawowe (Rzeczywisty)
1 stycznia 2011
Ukończenie studiów (Rzeczywisty)
1 stycznia 2011
Daty rejestracji na studia
Pierwszy przesłany
10 października 2008
Pierwszy przesłany, który spełnia kryteria kontroli jakości
10 października 2008
Pierwszy wysłany (Oszacować)
13 października 2008
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
9 lipca 2013
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
28 czerwca 2013
Ostatnia weryfikacja
1 czerwca 2013
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- 0601-09
- R01NR010004 (Grant/umowa NIH USA)
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrutacyjnyHIV | Test na HIV | Związek HIV z opieką | Leczenie HIVStany Zjednoczone
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement i inni współpracownicyNieznanyHIV | Dzieci niezakażone wirusem HIV | Dzieci narażone na HIVKamerun
-
University of MinnesotaWycofaneZakażenia wirusem HIV | HIV/AIDS | HIV | AIDS | Problem z AIDS/HIV | AIDS i infekcjeStany Zjednoczone
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationZakończonyPartnerskie testy na obecność wirusa HIV | Porady dotyczące HIV dla par | Komunikacja pary | Zapadalność na HIVKamerun, Republika Dominikany, Gruzja, Indie
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... i inni współpracownicyRekrutacyjnyHIV | Test na HIV | Połączenie z opiekąAfryka Południowa
-
CDC FoundationGilead SciencesNieznanyProfilaktyka przed ekspozycją na HIV | Chemioprofilaktyka HIVStany Zjednoczone
-
Hospital Clinic of BarcelonaZakończonyInhibitory integrazy, HIV; INHIB PROTEAZY HIVHiszpania
-
University of Maryland, BaltimoreWycofaneHIV | Przeszczep nerki | Zbiornik HIV | CCR5Stany Zjednoczone
-
Helios SaludViiV HealthcareNieznanyHIV | Zakażenie HIV-1Argentyna
-
Erasmus Medical CenterJeszcze nie rekrutacjaZakażenia wirusem HIV | HIV | Zakażenie HIV-1 | Zakażenie wirusem HIV IHolandia